Encouraging data in the race to regulate transcription factors such as Myc will be important because they will be a breakthrough - Phylogica is operating on the frontier of science where early success will open doors to a Big Pharma collaboration.
No-one is paying much attention at the moment because Myc is undruggable. Once a platform is established which opens the door to drug development then it will become a very hot space - rivalling immunotherapy.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |